Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PROSER1 is a chromatin-associated protein that regulates DNA demethylation during neurodevelopment by scaffolding and stabilizing complexes containing TET family DNA demethylases and OGT, a glycosyltransferase[1][3]. It promotes O-GlcNAcylation and stability of TET2, modulates recruitment of TET enzymes to chromatin, and affects histone modifications and enhancer activity[1][3]. Loss of PROSER1 leads to altered DNA methylation patterns and gene expression changes, particularly at CpG islands and enhancers, which can result in neurodevelopmental defects[1]. PROSER1 is highly conserved across mammals, with general cytoplasmic expression and enrichment in tissues such as lymph, embryonic tissue, thymus, and uterus[4][5]. While essential for proper epigenetic regulation and development, it is not currently considered a therapeutic target, and no interacting drugs are documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline and serine-rich protein 1 (PROSER1).